Healthcare IT Today

MARCH 15, 2024

When doctors, nurses, and other care workers are stretched thin by administrative tasks and busy work, there is the potential for it to become far more difficult for them to provide the kind of individualized care that patients deserve. We’re already seeing the benefits of AI-infused research in pharmaceuticals and drug development.

Pharmaceuticals 95

Pharmaceuticals Drug Development Mental health Nursing 95

Digital Health Global

NOVEMBER 2, 2023

Drug development The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates. There are three main advantages to the use of AI in drug development: width of research, speed of execution, low costs.

Drug Development 88

Drug Development Pharmaceuticals Public Health Telehealth 88

Digital Health Today

AUGUST 7, 2019

They have the potential to become a game changer in healthcare for patients, healthcare professionals, pharmaceuticals and insurance companies. The Digital Therapeutics Alliance developed a definition to differentiate DTx solutions from health and wellness apps. Digital Therapeutics (DTx) have been under the spotlight this past year.

Pharmaceuticals 70

Pharmaceuticals Digital Health Drug Development Primary Care 70

Healthcare IT News - Telehealth

JANUARY 20, 2022

Everyone from the board and the C-suite to the health IT team to doctors and nurses are talking about how digital technologies can change the industry and bring about better care and better outcomes. Digital transformation is the topic du jour in healthcare today. Decentralized clinical trials are already growing in popularity.

Life Science 190

Life Science Primary Care Mental health Drug Development 190

Xealth

JUNE 27, 2023

Its interest in DTx exists specifically in remote patient monitoring because of the potential to provide valuable insights throughout drug development life cycles. DTx has the potential to streamline data collection processes, help providers offer higher quality value-based care, and reduce the burden on doctors and nurses.

Digital Health 52

Digital Health Drug Development Pharmaceuticals EHR 52

Healthcare IT News - Telehealth

MAY 6, 2020

Biofourmis’ digital therapeutics are used for RPM across three primary healthcare stakeholder groups: health systems, payers and pharmaceutical companies. A provider present with the patient at one location – a nursing home, community clinic, etc.

Connected Health 184

Connected Health Telehealth Pharmaceuticals EHR 184